Supreme Petrochem Limited (NSE:SPLPETRO)
India · Delayed Price · Currency is INR | Market Cap | 155.28B |
| Revenue (ttm) | 58.29B |
| Net Income (ttm) | 3.50B |
| Shares Out | n/a |
| EPS (ttm) | 18.58 |
| PE Ratio | 44.43 |
| Forward PE | 32.53 |
| Dividend | 10.00 (1.25%) |
| Ex-Dividend Date | Jul 4, 2025 |
| Volume | 214,918 |
| Average Volume | 32,305 |
| Open | 784.05 |
| Previous Close | 786.20 |
| Day's Range | 784.05 - 835.40 |
| 52-Week Range | 518.05 - 910.00 |
| Beta | 0.40 |
| RSI | 56.26 |
| Earnings Date | Jul 18, 2025 |
About Ligand Pharmaceuticals
Supreme Petrochem Limited manufactures and sells polystyrene, expandable polystyrene, masterbatches and compounds of styrenics and other polymers, and extruded polystyrene insulation board in India and internationally. It provides general purpose and high impact polystyrene for injection moulding, extrusion, thermoforming, and blow moulding applications; expandable polystyrene (EPS) used in road and railway construction, and food industry; and acrylonitrile butadiene styrene (ABS), pre-colors, and specialties for automotives, household applianc... [Read more]
Financial Performance
In 2024, Supreme Petrochem's revenue was 60.16 billion, an increase of 14.61% compared to the previous year's 52.49 billion. Earnings were 3.91 billion, an increase of 12.71%.
Financial StatementsNews
Stocks to watch today: Supreme Petrochem posts 15.8% rise in net profit to ₹90.3 crore
Supreme Petrochem delivered strong quarterly results, with net profit increasing by 15.8% year-on-year to ₹90.3 crore. Revenue for the quarter grew by 17.8% to ₹1,505.6 crore, and EBITDA rose by 18% t...
Supreme Petrochem Q2 FY25 results: Revenue at Rs 1,500.44 crore up 17.8% YoY; Net profit at Rs 903.42 crore, up 15.7% YoY
Supreme Petrochem Ltd reported its financial results for the second quarter of FY25, showing strong growth in both revenue and net profit. The sale of products for the quarter ended September 30, 2024...